The Management of Co-Morbidities in Patients with Heart Failure – Angina and Coronary Disease | Zendy

Ilaria Spoletini | Zendy; Petar Seferović | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Management of Co-Morbidities in Patients with Heart Failure – Angina and Coronary Disease

Author(s) -

Ilaria Spoletini,

Petar Seferović

Publication year - 2017

Publication title -

international cardiovascular forum journal

Language(s) - English

Resource type - Journals

eISSN - 2410-2636

pISSN - 2409-3424

DOI - 10.17987/icfj.v10i0.451

Subject(s) - medicine , angina , coronary artery disease , heart failure , cardiology , quality of life (healthcare) , intensive care medicine , disease management , coronary heart disease , disease , comorbidity , myocardial infarction , nursing , parkinson's disease

Co-morbidities are particularly relevant in the management of HF as they may confound HF diagnosis, worsen symptomatology, impact quality of life and aggravate the prognosis. According to the most recent European Society of Cardiology (ESC) guidelines, treatment of co- morbidities is an essential element of the comprehensive care of HF. Angina and coronary artery disease (CAD), in particular are common disorders associated with HF. The pharmacological and surgical management of angina according to the ESC guidelines is reviewed in this article.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research